|
BIAF Bioaffinity Technologies Inc 1712762 |
| Income Statement |
|
Revenue
|
form10-q
|
2,350,386 |
|
Net Income
|
form10-q
|
-2,000,840 |
|
Profit Margin
|
|
-85.13% |
| Balance Sheet |
|
Current Assets
|
2,549,138 |
|
Assets
|
6,552,014 |
|
Current Liabilities
|
2,491,164 |
|
Liabilities
|
3,430,989 |
|
Equity
|
3,121,025 |
|
Shares Out
|
13,490,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-5,587,634 |
|
Investing Cash Flow
|
-79,082 |
| Market Analysis |
Market Cap
|
24,282,485 |
|
Price
|
0.27 |
|
BVPS
|
0.23 |
|
PB
|
1.21 |
|
EPS
|
-0.90 |
|
PS
|
2.58 |
|
FCF
|
-5,666,716 |
|
| Earnings |
|
| Apr |
May |
Jun |
| 4/01 |
|
5/15 |
-0.21 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BIAF documents filed with the SEC.
BIAF Filings
Clear
